Motexafin gadolinium for the treatment of metastatic renal cell carcinoma: phase II study results. (Q53450729)

From Wikidata
Jump to navigation Jump to search
scientific article published in September 2008
edit
Language Label Description Also known as
English
Motexafin gadolinium for the treatment of metastatic renal cell carcinoma: phase II study results.
scientific article published in September 2008

    Statements

    Motexafin gadolinium for the treatment of metastatic renal cell carcinoma: phase II study results. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit